STAT5A and cardiac hypertrophy: The STAT5 inhibitor substantially decreased inflammation in cardiac hypertrophy in Ang II-induced mice [35], and the STAT5 inhibitor significantly attenuated atherosclerosis via decreasing inflammation in ApoE−/− mice induced by HFD [36].